CANDIBRIX VAGINAL TABLET

CANDIBRIX VAGINAL TABLET

65 INR/Piece

Product Details:

  • Drug Type Specific Drug
  • Physical Form Tablets
  • Dosage 100 mg
  • Supply Ability : 10000 Piece Per Week
  • Click to view more
X

Price And Quantity

  • 65 INR/Piece
  • 10000 Piece

Product Specifications

  • Specific Drug
  • Tablets
  • 100 mg

Trade Information

  • Cash Advance (CA), Cash in Advance (CID), Telegraphic Transfer (T/T)
  • 10000 Piece Per Week
  • 1 Week
  • Free samples are available
  • 6 SUPPOSITRIES
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • WHO GMP COA FSC DOSSIER

Product Description

In a randomized, double-blind trial, the efficacy and safety of a new single-dose clotrimazole vaginal tablet were compared with that of three-day clotrimazole therapy. Forty-two patients with clinically and mycologically confirmed vulvo-vaginal candidiasis received either one 500-mg clotrimazole tablet for one day or two 100-mg tablets daily for three days. Follow-up visits were performed approximately one week and one month after treatment. Thirty-six patients were evaluated for drug efficacy. There was no significant difference in clinical and mycological responses to the two regimens (P = 1.00, Fisher's exact test). At the final visit, 16 (89%) of the 18 patients receiving one-day treatment showed mycological and clinical clearance of infection, as compared to 15 (83%) of the 18 patients receiving three-day therapy. One patient in the three-day treatment group presented moderate edema of the vulva which was judged to be remotely related to treatment. The findings indicate that a single 500-mg tablet of clotrimazole is as effective and safe in the treatment of vulvovaginal candidiasis as a three-day course of 200 mg/day
Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Hormonal Injections & Tablets' category



"Accepting orders in bulk order quantity".
DHEER HEALTHCARE PRIVATE LIMITED All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.